Special clinical syndromes

Recent Advances in IgA Nephropathy

Volumn , Issue , 2009, Pages 121-138

  Nagy, Judit ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969677551     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812835871_0009     Document Type: Chapter

References (84)

1. Mustonen J. (1984) IgA glomerulonephritis and associated diseases. Ann Clin Res 16: 161-166.
2. Makdassy R, Beaufils M, Meyrier A, et al. (1984) Pathologic conditions associated with IgA nephropathy: preliminary results. Contr Nephrol 40: 292-295.
3. Barratt J, Feechally J. (2005) IgA nephropathy. J Am Soc Nephrol 16: 2088-2097.
4. Fouria S, Barratt J. (2008) Secondary IgA nephropathy. Semin Nephrol 28: 37-37.
5. Sanders JT, Wyatt RJ. (2008) IgA nephropathy and Henoch-Schonlein purpura nephritis. Curr Opin Pediat 20: 163-170.
6. Sinniah R. (1983) Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Path 36: 276-279.
7. Suzuki K, Honda K, Tanabe K, et al. (2003) Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294.
8. Nagy J, Bajtai G, Brasch H, et al. (1979) The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. Clin Nephrol 12: 109-116.
9. Lai KN, Lai FM, Chan KW, et al. (1987) The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med 63: 323-333.
10. Wang LS, Wu ZL, Zhang Y, et al. (2003) Role of hepatitis B virus infection in pathogenesis of IgA nephropathy. World J Gastroenterol 9: 2004-2008.
11. Wang LS, Wu ZL, Zhang Y, Liao LT. (2005) Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathy. World J Gastroenterol 11: 712-716.
12. McGuire BM, Julian BA, Bynon JS, Jr, et al. (2006) Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144: 735-741.
13. Weiner NJ, Goodman JW, Kimmel PL. (2003) The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int 63: 1618-1631.
14. Kimmel PL, Phillips TM, Ferreira-Centeno A, et al. (1993) HIV-associated immune-mediated renal disease. Kidney Int 44: 1327-1340.
15. Beaufils H, Jouanneau C, Katlama C, et al. (1995) HIV-associated IgA nephropathy — a post-mortem study. Nephrol Dial Transplant 10: 35-38.
16. Kobayashi M, Koyama A. (1998) Methicillin-resistant Staphylococcus aureus (MRSA) infection in glomerulonephritis — a novel hazard emerging on the horizon. Nephrol Dial Transplant 13: 2999-3001.
17. Long JA, Cook WJ. (2006) IgA deposits and acute glomerulonephritis in a patient with staphylococcal infection. Am J Kidney Dis 48: 851-855.
18. Satoskar A, Nadasdy Gy, Plaza JA, et al. (2006) Staphylococcus infection- associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol 1: 1179-1186.
19. Arakawa Y, Shimizu Y, Sakurai H, et al. (2006) Polyclonal activation of an IgA subclass against Staphylococcus aureus cell membrane antigen in post-methicillin-resistant S. aureus infection glomerulonephritis. Nephrol Dial Transplant 21: 1448-1449.
20. Sharmin S, Shimizu Y, Hagiwara M, et al. (2004) Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol 17: 504-511.
21. Koyama A, Sharmin S, Sakurai H, et al. (2004) Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int 66: 121-132.
22. Newell GC. (1987) Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis 9: 183-190.
23. Nakamoto Y, Iida H, Kobayashi K, et al. (1981) Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part. Virchows Arch A Pathol Anat Histol 392: 45-54.
24. ManIgAnd G, Taillandier J, Morel-Maroger L, et al. (1981) Glomerular nephropathies in hepatic cirrhosis. Ann Med Interne (Paris) 132: 178-182.
25. Pouria S, Fechally J. (1999) Glomerular IgA deposition in liver disease. Nephrol Dial Transplant 14: 2279-2282.
26. Lomax-Smith JD, Zabrowarny LA, Howarth GS, et al. (1983) The immunochemical characterisation of mesangial IgA deposits. Am J Pathol 113: 359-364.
27. Nochy D, Callard P Bellon B, et al. (1976) Association of overt glomerulonephritis and liver disease: a study of 34 patients. Clin Nephrol 6: 422-427.
28. van de Wiel A, Schuurman HJ, Kater L. (1987) Alcoholic liver disease: an IgA-associated disorder. Scand J Gastroenterol 22: 1025-1030.
29. 1O-glycan alterations by MALDI mass spectrometry in patients with renal and hepatic diseases of heterogeneous aetiology. In: 12th International Congress of Mucosal Immunology, Boston, MA (Abstract).
30. Murray JA. (1999) The widening spectrum of celiac disease. Am J Clin Nutr 69: 354-365.
31. Farrell RJ, Kelly CP (2002) Celiac sprue. N Engl J Med 346: 180-188.
32. Pasternack A, Collin P Mustonen J, et al. (1990) Glomerular IgA deposits in patients with celiac disease. Clin Nephrol 35: 56-60.
33. Helin H, Mustonen J, Reunala T, et al. (1983) IgA nephropathy associated with celiac disease and dermatitis herpetiformis. Arch Pathol Lab Med 107: 324-327.
34. Nagy J, Scott H, Brandtzaeg P (1988) Antibodies to dietary antigens in IgA nephropathy. Clin Nephrol 2: 275-279.
35. Laurent J, Branellec A, Heslan JM, et al. (1987) An increase in circulating IgA antibodies to gliadin in IgA mesangial glomerulonephritis. Am J Nephrol 7: 178-183.
36. Fornasieri A, Sinico RA, Maldifassi P et al. (1987) IgA-antigliadin antibodies in IgA meseangial nephropathy (Berger’s disease). Br Med J 295: 78-80.
37. Pierucci A, Fofi C, Bartoli B, et al. (2002) Antiendomysial antibodies in Berger’s disease. Am J Kidney Dis 39: 1176-1182.
38. Rostoker G, Andre C, Bourhala S, et al. (1988) Lack of antireticulin and IgA antiendomysium antibodies in sera of patients with primary IgA nephropathy associated with circulating IgA antibodies to gliadin. Nephron 48: 81.
39. Kovacs T, Kun L, Schmelczer M, et al. (1996) Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. Am J Nephrol 16: 500-505.
40. Sategna-Guidetti C, Ferfoglia G, Bruno M, et al. (1992) Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? Gut 33: 476-478.
41. Rostoker G, Laurent J, Andre C, et al. (1988) High levels of IgA antigliadin antibodies in patients who have IgA mesangial glomerulonephritis but not coeliac disease. Lancet 1: 356-357.
42. Coppo R, Roccatello D, Amore A, et al. (1990) Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 33: 72-86.
43. Woodrow G, Innes A, Boyd SM, et al. (1993) A case of IgA nephropathy with coeliac disease responding to a gluten-free diet. Nephrol Dial Transplant 8: 1382-1383.
44. Collin P Syrjanen J, Partanen J, et al. (2002) Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol 97: 2572-2576.
45. Rantala J, Collin P Holm K, et al. (1999) Small bowel T cells, HLA class II antigen DR and GroEL stress protein in IgA nephropathy. Kidney Int 55: 2274-2280.
46. Forshaw MJ, Guirguis O, HennIgAn TW. (2005) IgA nephropathy in association with Crohn’s disease. Int J Colorectal Dis 20: 463-465.
47. Takemura T, Okada M, Yagi K, et al. (2002) An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications. Pediatr Nephrol 17: 863-866.
48. Hirsch DJ, Jindal KK, Trillo A, et al. (1992) Acute renal failure in Crohn’s disease due to IgA nephropathy. Am J Kidney Dis 2: 189-190.
49. McCallum D, Smith L, Harley F, et al. (1997) IgA nephropathy and thin basement membrane disease in association with Crohn disease. Pediatr Nephrol 11: 637-640.
50. Toyoda H, Wang SJ, Yang HJ. (1993) Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 104: 741-748.
51. Friedman BI, Spray BJ, Heise ER. (1994) HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis 23: 352-357.
52. Hubert D, Beaufils M, Meyrier A. (1984) Immunoglobulin A glomerular nephropathy associated with inflammatory colitis. Apropos of 2 cases. Presse Med 13: 1083-1085.
53. Iida H, Asaka M, Izumino K, et al. (1989) IgA nephropathy complicated by ulcerative colitis. Nephron 53: 285-286.
54. Trimarchi HM, Freixas EAR, Peters R, et al. (2001) Immunoglobulin A nephropathy and ulcerative colitis. Am J Nephrol 21: 400-405.
55. Onime A, Agaba EI, Sun Y, et al. (2006) Immunoglobulin A nephropathy complicating ulcerative colitis. Int Urol Nephrol 38: 349-353.
56. Sinniah R. (1982) Mucin secreting cancer with mesangial IgA deposits. Pathology 14: 303-308.
57. Mustonen J, Pasternack A, Helin H. (1984) IgA mesangial nephropathy in neoplastic diseases. Contr Nephrol 40: 283-291.
58. Endo Y, Hara M. (1986) Glomerulat IgA deposition in pulmonary diseases. Kidney Int 29: 557-562.
59. Magyarlaki T, Kiss B, Buzogany I, et al. (1999) Renal cell carcinoma and paraneoplastic IgA nephropathy. Nephron 82: 127-130.
60. Beaufils H, Patte R, Aubert Ph, et al. (1984) Renal immunopathology in renal cell carcinoma. Virchows Arch (Pathol Anat) 404: 87-97.
61. Zickerman AM, Allen AC, Talwar V, et al. (2000) IgA myeloma presenting as Henoch-Schonlein purpura with nephritis. Am J Kidney Dis 36: E19.
62. Bianchini G, Festuccia F, Laverde G, Cinotti GA. (1999) IgA myeloma: a potential outcome of IgA nephropathy. Nephrol Dial Transplant 14: 2780-2781.
63. Triolo G, Giardina E, Rinaldi A, Bompiani G. (1987) Serum hyper-IgA in diabetes. I. Increase in the proportion of the polymeric to the monomeric form. Boll Ist Sieroter Milan 63: 173-174.
64. Yavuzyilmaz E, Yumak O, Akdoganil T, et al. (1996) The alterations of whole saliva constituents in patients with diabetes mellitus. Aust Dent J 41: 193-197.
65. Mak SK, Wong PN, Lo KY, Tong G, Wong A. (2001) Prospective study on renal outcome of IgA nephropathy superimposed on diabetic glomerulosclerosis on type 2 diabetic patients. Nephrol Dial Transplant 16: 1183-1188.
66. Lai FM, Li PK, Pang SW, et al. (1993) Diabetic patients with IgA nephropathy and diabetic glomerulosclerosis. Mod Pathol 6: 684-690.
67. Sessa A, Meroni M, Battini G, et al. (1998) IgA nephropathy complicating diabetic glomerulosclerosis. Nephron 80: 488-489.
68. Orfila C, Lepert JC, Modesto A, Pipy B, Suc JM. (1998) IgA nephropathy complicating diabetic glomerulosclerosis. Nephron 79: 279-287.
69. Pasquariello A, Innocenti M, Sami N, et al. (2008) Hashimoto’s thyreoidi- tis and IgA nephropathy an underestimated association? Nephrol Dial Transplant Plus 1(Suppl 2): ii298 (Abstract).
70. Zadrazil J, Tichy T, Horak P et al. (2006) IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of “psoriatic nephropathy.” J Nephrol 19: 382-386.
71. Shu KH, Lian JD, Yang YF, et al. (1986) Glomerulonephritis in ankylosing spondylitis. Clin Nephrol 25(4): 169-174.
72. Bailey RR, Burry AF, McGiven AR, et al. (1980) A renal lesion in ankylosing spondylitis. Nephron 26: 171-173.
73. Nakano M, Ueno M, Nishi S, et al. (1996) Determination of IgA- and IgM- rheumatoid factors in patients with rheumatoid arthritis with or without nephropathy. Ann Rheum Dis 55: 520-524.
74. Sato M, Kojima H, Koshikawa S. (1998) IgA nephropathy in rheumatoid arthritis. Nephron 48: 169-170.
75. Korpela M, Mustonen J, Teppo AM, et al. (1997) Mesangial glomerulonephritis as an extra-articular manifestation of rheumatoid arthritis. Br J Rheumatol 36: 1189-1195.
76. Kemp E, Nielsen H, Petersen LJ, et al. (2001) Newer immunomodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis. Clin Nephrol 55: 87-88.
77. Haas M, Jafri J, Bartosh SM, et al. (2000) ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis 36(4): 709-718.
78. Winters MJ, Hurley RM, Lirenman DS. (2002) ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol 17: 257-260.
79. Amir ARA, Sheikh SS. (2002) ANCA-associated crescentic IgA glomerulonephritis in pregnancy. J Nephrol 25: 716-719.
80. Allmaras E, Nowack R, Andrassy K, et al. (1997) Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol 48: 269-273.
81. Martin SJ, Audrain MA, Baranger T, et al. (1997) Recurrence of immunoglobulin A nephropathy with immunoglobulin A antineutrophil cytoplasmic antibodies following renal transplantation. Am J Kidney Dis 29: 125-131.
82. Cavatorta F, Campisi S, Trabassi E, Zollo A, Salvidio G. (1995) IgA nephropathy associated with Takayasu’s arteritis: report of a case and review of the literature. Am J Nephrol 15: 165-167.
83. Ramirez SB, Rosen S, Niles J, Somers MJ. (1998) IgG antineutrophil cytoplasmic antibodies in IgA nephropathy: a clinical variant? Am J Kidney Dis 31: 341-344.
84. Andrassy K, Waldherr R, Erb A, Ritz E. (1992) De novo glomerulonephritis in patients during remission from Wegener’s granulomatosis. Clin Nephrol 38: 295-298.